|
|
 |
|
Viewing report
|
|
|
|
Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report
iCD Research, Feb 2012, Pages: 18
Synopsis
ICD Research's 'Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
ICD Research's 'Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report' is a crucial resource for industry executives and anyone looking to access key information about Apotex, Inc..
ICD Research's 'Apotex, Inc: Pharmaceuticals and Healthcare Company Profile & SWOT Report' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about 'Apotex, Inc.' for business intelligence requirements.
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile also contains information on business operations, company history, major products and services, prospects, key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of 'Apotex, Inc.'.
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
Key Highlights
Apotex Inc. (Apotex) is one of the leading generic drugmakers in Canada. The company engages in the research, development, manufacture and distribution of generic drugs in Canada and internationally. The company produces around 300 generic drugs in more than 4,000 dosages and formats. It also develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, disposable plastics, packaging components, and medical devices for medical use. Through agreement and subsidiaries, Apotex exports to more than 115 countries across Turkey, Belgium, Australia, Czech Republic, Netherlands, Mexico, Poland, New Zealand, and the UK. The company is headquartered in Toronto, Canada.
|
|
|
|
